Loading…

Design, synthesis and biological activities of echinopsine derivatives containing acylhydrazone moiety

Based on the broad-spectrum biological activities of echinopsine and acylhydrazones, a series of echinopsine derivatives containing acylhydrazone moieties have been designed, synthesized and their biological activities were evaluated for the first time. The bioassay results indicated that most of th...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2022-02, Vol.12 (1), p.2935-2935, Article 2935
Main Authors: Cui, Peipei, Cai, Mingjiang, Meng, Yanan, Yang, Yan, Song, Hongjian, Liu, Yuxiu, Wang, Qingmin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623
cites cdi_FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623
container_end_page 2935
container_issue 1
container_start_page 2935
container_title Scientific reports
container_volume 12
creator Cui, Peipei
Cai, Mingjiang
Meng, Yanan
Yang, Yan
Song, Hongjian
Liu, Yuxiu
Wang, Qingmin
description Based on the broad-spectrum biological activities of echinopsine and acylhydrazones, a series of echinopsine derivatives containing acylhydrazone moieties have been designed, synthesized and their biological activities were evaluated for the first time. The bioassay results indicated that most of the compounds showed moderate to good antiviral activities against tobacco mosaic virus (TMV), among which echinopsine ( I ) (inactivation activity, 49.5 ± 4.4%; curative activity, 46.1 ± 1.5%; protection activity, 42.6 ± 2.3%) and its derivatives 1 (inactivation activity, 44.9 ± 4.6%; curative activity, 39.8 ± 2.6%; protection activity, 47.3 ± 4.3%), 3 (inactivation activity, 47.9 ± 0.9%; curative activity, 43.7 ± 3.1%; protection activity, 44.6 ± 3.3%), 7 (inactivation activity, 46.2 ± 1.6%; curative activity, 45.0 ± 3.7%; protection activity, 41.7 ± 0.9%) showed higher anti-TMV activity in vivo at 500 mg/L than commercial ribavirin (inactivation activity, 38.9 ± 1.4%; curative activity, 39.2 ± 1.8%; protection activity, 36.4 ± 3.4%). Some compounds exhibited insecticidal activities against Plutella xylostella , Mythimna separate and Spodoptera frugiperda. Especially, compounds 7 and 27 displayed excellent insecticidal activities against Plutella xylostell (mortality 67 ± 6% and 53 ± 6%) even at 0.1 mg/L. Additionally, most echinopsine derivatives exhibited high fungicidal activities against Physalospora piricola and Sclerotinia sclerotiorum .
doi_str_mv 10.1038/s41598-022-06775-7
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_de74cc71fa1b4b3792eb6bf8a24e0848</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_de74cc71fa1b4b3792eb6bf8a24e0848</doaj_id><sourcerecordid>2631865722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623</originalsourceid><addsrcrecordid>eNp9kktv1DAUhSMEolXpH2CBIrFhQYrfTjZIqDxaqRIbWFvXr4xHGXuwMyNNfz2eppSWBd74yue7x9fWaZrXGF1gRPsPhWE-9B0ipENCSt7JZ80pQYx3hBLy_FF90pyXskZ1cTIwPLxsTijHAxJoOG38Z1fCGN-35RDnVa1LC9G2OqQpjcHA1IKZwz7MwZU2-daZVYhpW0J0rXU57KGqVTIpzhBiiGNtOEyrg81wmyq0ScHNh1fNCw9Tcef3-1nz8-uXH5dX3c33b9eXn246wxmauwEjqwkSPceEeEs8JhisAAygNQUmejdIb7kABmAENVx7jI00lFGBBaFnzfXiaxOs1TaHDeSDShDU3UHKo4I8BzM5ZZ1kxkjsAWumqRyI00L7HghzqGd99fq4eG13euOscXHOMD0xfarEsFJj2qu-FxhxVg3e3Rvk9Gvnyqw2oRg3TRBd2hVFBMW94JIc5377D7pOuxzrVx0pJBkZ6JEiC2VyKiU7_zAMRuqYCrWkQtVUqLtUKFmb3jx-xkPLnwxUgC5AqVIcXf57939sfwPqDMT7</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2630742932</pqid></control><display><type>article</type><title>Design, synthesis and biological activities of echinopsine derivatives containing acylhydrazone moiety</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Cui, Peipei ; Cai, Mingjiang ; Meng, Yanan ; Yang, Yan ; Song, Hongjian ; Liu, Yuxiu ; Wang, Qingmin</creator><creatorcontrib>Cui, Peipei ; Cai, Mingjiang ; Meng, Yanan ; Yang, Yan ; Song, Hongjian ; Liu, Yuxiu ; Wang, Qingmin</creatorcontrib><description>Based on the broad-spectrum biological activities of echinopsine and acylhydrazones, a series of echinopsine derivatives containing acylhydrazone moieties have been designed, synthesized and their biological activities were evaluated for the first time. The bioassay results indicated that most of the compounds showed moderate to good antiviral activities against tobacco mosaic virus (TMV), among which echinopsine ( I ) (inactivation activity, 49.5 ± 4.4%; curative activity, 46.1 ± 1.5%; protection activity, 42.6 ± 2.3%) and its derivatives 1 (inactivation activity, 44.9 ± 4.6%; curative activity, 39.8 ± 2.6%; protection activity, 47.3 ± 4.3%), 3 (inactivation activity, 47.9 ± 0.9%; curative activity, 43.7 ± 3.1%; protection activity, 44.6 ± 3.3%), 7 (inactivation activity, 46.2 ± 1.6%; curative activity, 45.0 ± 3.7%; protection activity, 41.7 ± 0.9%) showed higher anti-TMV activity in vivo at 500 mg/L than commercial ribavirin (inactivation activity, 38.9 ± 1.4%; curative activity, 39.2 ± 1.8%; protection activity, 36.4 ± 3.4%). Some compounds exhibited insecticidal activities against Plutella xylostella , Mythimna separate and Spodoptera frugiperda. Especially, compounds 7 and 27 displayed excellent insecticidal activities against Plutella xylostell (mortality 67 ± 6% and 53 ± 6%) even at 0.1 mg/L. Additionally, most echinopsine derivatives exhibited high fungicidal activities against Physalospora piricola and Sclerotinia sclerotiorum .</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-022-06775-7</identifier><identifier>PMID: 35190609</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>639/638/309 ; 639/638/403 ; 639/638/549 ; Animals ; Antifungal Agents ; Antiviral Agents ; Ascomycota - drug effects ; Bioassays ; Biological activity ; Design ; Drug Design - methods ; Granulovirus - drug effects ; Humanities and Social Sciences ; Hydrazones - chemistry ; Inactivation ; Insecticides ; multidisciplinary ; Natural products ; Quinolones - chemical synthesis ; Quinolones - chemistry ; Quinolones - pharmacology ; Ribavirin ; Science ; Science (multidisciplinary) ; Spodoptera - drug effects ; Tobacco ; Tobacco Mosaic Virus - drug effects ; Viruses</subject><ispartof>Scientific reports, 2022-02, Vol.12 (1), p.2935-2935, Article 2935</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623</citedby><cites>FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623</cites><orcidid>0000-0002-6062-3766</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2630742932/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2630742932?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35190609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cui, Peipei</creatorcontrib><creatorcontrib>Cai, Mingjiang</creatorcontrib><creatorcontrib>Meng, Yanan</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><creatorcontrib>Song, Hongjian</creatorcontrib><creatorcontrib>Liu, Yuxiu</creatorcontrib><creatorcontrib>Wang, Qingmin</creatorcontrib><title>Design, synthesis and biological activities of echinopsine derivatives containing acylhydrazone moiety</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Based on the broad-spectrum biological activities of echinopsine and acylhydrazones, a series of echinopsine derivatives containing acylhydrazone moieties have been designed, synthesized and their biological activities were evaluated for the first time. The bioassay results indicated that most of the compounds showed moderate to good antiviral activities against tobacco mosaic virus (TMV), among which echinopsine ( I ) (inactivation activity, 49.5 ± 4.4%; curative activity, 46.1 ± 1.5%; protection activity, 42.6 ± 2.3%) and its derivatives 1 (inactivation activity, 44.9 ± 4.6%; curative activity, 39.8 ± 2.6%; protection activity, 47.3 ± 4.3%), 3 (inactivation activity, 47.9 ± 0.9%; curative activity, 43.7 ± 3.1%; protection activity, 44.6 ± 3.3%), 7 (inactivation activity, 46.2 ± 1.6%; curative activity, 45.0 ± 3.7%; protection activity, 41.7 ± 0.9%) showed higher anti-TMV activity in vivo at 500 mg/L than commercial ribavirin (inactivation activity, 38.9 ± 1.4%; curative activity, 39.2 ± 1.8%; protection activity, 36.4 ± 3.4%). Some compounds exhibited insecticidal activities against Plutella xylostella , Mythimna separate and Spodoptera frugiperda. Especially, compounds 7 and 27 displayed excellent insecticidal activities against Plutella xylostell (mortality 67 ± 6% and 53 ± 6%) even at 0.1 mg/L. Additionally, most echinopsine derivatives exhibited high fungicidal activities against Physalospora piricola and Sclerotinia sclerotiorum .</description><subject>639/638/309</subject><subject>639/638/403</subject><subject>639/638/549</subject><subject>Animals</subject><subject>Antifungal Agents</subject><subject>Antiviral Agents</subject><subject>Ascomycota - drug effects</subject><subject>Bioassays</subject><subject>Biological activity</subject><subject>Design</subject><subject>Drug Design - methods</subject><subject>Granulovirus - drug effects</subject><subject>Humanities and Social Sciences</subject><subject>Hydrazones - chemistry</subject><subject>Inactivation</subject><subject>Insecticides</subject><subject>multidisciplinary</subject><subject>Natural products</subject><subject>Quinolones - chemical synthesis</subject><subject>Quinolones - chemistry</subject><subject>Quinolones - pharmacology</subject><subject>Ribavirin</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Spodoptera - drug effects</subject><subject>Tobacco</subject><subject>Tobacco Mosaic Virus - drug effects</subject><subject>Viruses</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kktv1DAUhSMEolXpH2CBIrFhQYrfTjZIqDxaqRIbWFvXr4xHGXuwMyNNfz2eppSWBd74yue7x9fWaZrXGF1gRPsPhWE-9B0ipENCSt7JZ80pQYx3hBLy_FF90pyXskZ1cTIwPLxsTijHAxJoOG38Z1fCGN-35RDnVa1LC9G2OqQpjcHA1IKZwz7MwZU2-daZVYhpW0J0rXU57KGqVTIpzhBiiGNtOEyrg81wmyq0ScHNh1fNCw9Tcef3-1nz8-uXH5dX3c33b9eXn246wxmauwEjqwkSPceEeEs8JhisAAygNQUmejdIb7kABmAENVx7jI00lFGBBaFnzfXiaxOs1TaHDeSDShDU3UHKo4I8BzM5ZZ1kxkjsAWumqRyI00L7HghzqGd99fq4eG13euOscXHOMD0xfarEsFJj2qu-FxhxVg3e3Rvk9Gvnyqw2oRg3TRBd2hVFBMW94JIc5377D7pOuxzrVx0pJBkZ6JEiC2VyKiU7_zAMRuqYCrWkQtVUqLtUKFmb3jx-xkPLnwxUgC5AqVIcXf57939sfwPqDMT7</recordid><startdate>20220221</startdate><enddate>20220221</enddate><creator>Cui, Peipei</creator><creator>Cai, Mingjiang</creator><creator>Meng, Yanan</creator><creator>Yang, Yan</creator><creator>Song, Hongjian</creator><creator>Liu, Yuxiu</creator><creator>Wang, Qingmin</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6062-3766</orcidid></search><sort><creationdate>20220221</creationdate><title>Design, synthesis and biological activities of echinopsine derivatives containing acylhydrazone moiety</title><author>Cui, Peipei ; Cai, Mingjiang ; Meng, Yanan ; Yang, Yan ; Song, Hongjian ; Liu, Yuxiu ; Wang, Qingmin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>639/638/309</topic><topic>639/638/403</topic><topic>639/638/549</topic><topic>Animals</topic><topic>Antifungal Agents</topic><topic>Antiviral Agents</topic><topic>Ascomycota - drug effects</topic><topic>Bioassays</topic><topic>Biological activity</topic><topic>Design</topic><topic>Drug Design - methods</topic><topic>Granulovirus - drug effects</topic><topic>Humanities and Social Sciences</topic><topic>Hydrazones - chemistry</topic><topic>Inactivation</topic><topic>Insecticides</topic><topic>multidisciplinary</topic><topic>Natural products</topic><topic>Quinolones - chemical synthesis</topic><topic>Quinolones - chemistry</topic><topic>Quinolones - pharmacology</topic><topic>Ribavirin</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Spodoptera - drug effects</topic><topic>Tobacco</topic><topic>Tobacco Mosaic Virus - drug effects</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cui, Peipei</creatorcontrib><creatorcontrib>Cai, Mingjiang</creatorcontrib><creatorcontrib>Meng, Yanan</creatorcontrib><creatorcontrib>Yang, Yan</creatorcontrib><creatorcontrib>Song, Hongjian</creatorcontrib><creatorcontrib>Liu, Yuxiu</creatorcontrib><creatorcontrib>Wang, Qingmin</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cui, Peipei</au><au>Cai, Mingjiang</au><au>Meng, Yanan</au><au>Yang, Yan</au><au>Song, Hongjian</au><au>Liu, Yuxiu</au><au>Wang, Qingmin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, synthesis and biological activities of echinopsine derivatives containing acylhydrazone moiety</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2022-02-21</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>2935</spage><epage>2935</epage><pages>2935-2935</pages><artnum>2935</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Based on the broad-spectrum biological activities of echinopsine and acylhydrazones, a series of echinopsine derivatives containing acylhydrazone moieties have been designed, synthesized and their biological activities were evaluated for the first time. The bioassay results indicated that most of the compounds showed moderate to good antiviral activities against tobacco mosaic virus (TMV), among which echinopsine ( I ) (inactivation activity, 49.5 ± 4.4%; curative activity, 46.1 ± 1.5%; protection activity, 42.6 ± 2.3%) and its derivatives 1 (inactivation activity, 44.9 ± 4.6%; curative activity, 39.8 ± 2.6%; protection activity, 47.3 ± 4.3%), 3 (inactivation activity, 47.9 ± 0.9%; curative activity, 43.7 ± 3.1%; protection activity, 44.6 ± 3.3%), 7 (inactivation activity, 46.2 ± 1.6%; curative activity, 45.0 ± 3.7%; protection activity, 41.7 ± 0.9%) showed higher anti-TMV activity in vivo at 500 mg/L than commercial ribavirin (inactivation activity, 38.9 ± 1.4%; curative activity, 39.2 ± 1.8%; protection activity, 36.4 ± 3.4%). Some compounds exhibited insecticidal activities against Plutella xylostella , Mythimna separate and Spodoptera frugiperda. Especially, compounds 7 and 27 displayed excellent insecticidal activities against Plutella xylostell (mortality 67 ± 6% and 53 ± 6%) even at 0.1 mg/L. Additionally, most echinopsine derivatives exhibited high fungicidal activities against Physalospora piricola and Sclerotinia sclerotiorum .</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35190609</pmid><doi>10.1038/s41598-022-06775-7</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-6062-3766</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2022-02, Vol.12 (1), p.2935-2935, Article 2935
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_de74cc71fa1b4b3792eb6bf8a24e0848
source Publicly Available Content Database; PubMed Central; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 639/638/309
639/638/403
639/638/549
Animals
Antifungal Agents
Antiviral Agents
Ascomycota - drug effects
Bioassays
Biological activity
Design
Drug Design - methods
Granulovirus - drug effects
Humanities and Social Sciences
Hydrazones - chemistry
Inactivation
Insecticides
multidisciplinary
Natural products
Quinolones - chemical synthesis
Quinolones - chemistry
Quinolones - pharmacology
Ribavirin
Science
Science (multidisciplinary)
Spodoptera - drug effects
Tobacco
Tobacco Mosaic Virus - drug effects
Viruses
title Design, synthesis and biological activities of echinopsine derivatives containing acylhydrazone moiety
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A07%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20synthesis%20and%20biological%20activities%20of%20echinopsine%20derivatives%20containing%20acylhydrazone%20moiety&rft.jtitle=Scientific%20reports&rft.au=Cui,%20Peipei&rft.date=2022-02-21&rft.volume=12&rft.issue=1&rft.spage=2935&rft.epage=2935&rft.pages=2935-2935&rft.artnum=2935&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-022-06775-7&rft_dat=%3Cproquest_doaj_%3E2631865722%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-910db20685122fd2f121ad6a1aabb3a468e97fd56a4aac63c5bf11c7c34361623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2630742932&rft_id=info:pmid/35190609&rfr_iscdi=true